An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...

Methods: A 12-week, parallel, single-blind randomized controlled trial was conducted with 123 participants (62/123, 50%, female; mean age 58.25 years, SD 9.46 years) recently diagnosed with T2D.

New human research reveals how gut bacteria and creatine may restore brain energy and improve depression. If you have or know ...

Research shows that our gut microbiome — the trillions of microbes that populate our intestines — isn't just involved in digestion. It's intimately linked to our immune systems, mental health, ...

Abstract: Safety and data efficiency are important concerns in data-driven control, especially for nonlinear systems with unknown dynamics and subject to disturbances. In this work, we consider a ...

With totem-pole bridgeless power factor correction (PFC) offering the best efficiency among all PFC topologies, digital control can further push the efficiency capabilities of this topology to new ...

Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...

Average current-mode control, as shown in Figure 1, is common in continuous-conduction-mode (CCM) power factor correction (PFC). It has two loops: a voltage loop that works as an outer loop and a ...

This 40sqm cabin, known as The Pod, is designed as a complete living system. Every function — sleeping, cooking, working — is integrated with precision. Instead of space, the design prioritizes ...

A new study in the American Journal of Preventive Medicine reports findings from a randomized controlled trial—the gold standard study design in health research—showing that promoting drinking water ...

The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...

Methods: YOSEMITE is a phase 3, randomized, double-blind, placebo-controlled trial. Key inclusion criteria are genetically confirmed HoFH or a clinical diagnosis (total cholesterol >500 mg/dL OR ...